Production (Stage)
Dr. Reddy's Laboratories Limited
RDY
$15.80
-$0.37-2.29%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.69% | 3.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.69% | 3.40% | |||
| Cost of Revenue | 6.81% | 5.72% | |||
| Gross Profit | -5.97% | 1.83% | |||
| SG&A Expenses | -2.66% | 3.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -216.54% | 22.85% | |||
| Total Operating Expenses | 1.85% | 3.57% | |||
| Operating Income | -9.51% | 2.81% | |||
| Income Before Tax | 4.42% | -3.03% | |||
| Income Tax Expenses | -13.24% | -18.90% | |||
| Earnings from Continuing Operations | 10.34% | 3.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -32.20% | 110.93% | |||
| Net Income | 10.05% | 11.65% | |||
| EBIT | -9.51% | 2.81% | |||
| EBITDA | -13.97% | 5.50% | |||
| EPS Basic | 10.06% | 11.62% | |||
| Normalized Basic EPS | 2.62% | 2.38% | |||
| EPS Diluted | 10.07% | 11.57% | |||
| Normalized Diluted EPS | 2.63% | 2.45% | |||
| Average Basic Shares Outstanding | -0.01% | 0.04% | |||
| Average Diluted Shares Outstanding | -0.03% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -1.00% | |||